Before surgery, breast cancer patients had somewhat higher sTGFβrIII then healthy women, or those with benign breast lesions (by 14.5 and 26 ng/mL, respectively), with a tendency of larger differences at higher age. This correlated with lower expression of TGFβrIII in breast cancer vs. ...
[发明专利]TGFbRIII蛋白作为胃癌血清生物标志物的应用在审 专利信息 申请号:202210684890.7申请日:2022-06-13 公开(公告)号:CN114966029A公开(公告)日:2022-08-30 发明(设计)人:孙维建;沈贤;南如斌;吴昊;刘帅;王旭辉;梁丹娜;易永东;陈江楠;卢建华申请(专利权)人:温州医科大学附属第二医院(温州医科大学附属育英...
TGFbRIII蛋白作为胃癌血清生物标志物的应用本申请提供了一种TGFb RIII蛋白作为胃癌血清生物标志物的应用,本申请的有益之处在于:提供了一种TGFb RIII蛋白作为胃癌血清生物标志物的应用.孙维建沈贤南如斌吴昊刘帅王旭辉梁丹娜易永东陈江楠卢建华